Cargando…
Stereotactic Comparison Study of (18)F-Alfatide and (18)F-FDG PET Imaging in an LLC Tumor-Bearing C57BL/6 Mouse Model
This study aimed to stereotactically compare the PET imaging performance of (18)F-Alfatide ((18)F-ALF-NOTA-PRGD(2), denoted as (18)F-Alfatide) and (18)F-fluorodeoxyglucose (FDG) and immunohistochemistry (IHC) staining in Lewis lung carcinoma (LLC) tumor-bearing C57BL/6 mouse model. (18)F-FDG standar...
Autores principales: | Wei, Yu-Chun, Gao, Yongsheng, Zhang, Jianbo, Fu, Zheng, Zheng, Jinsong, Liu, Ning, Hu, Xudong, Hou, Wenhong, Yu, Jinming, Yuan, Shuanghu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923897/ https://www.ncbi.nlm.nih.gov/pubmed/27350554 http://dx.doi.org/10.1038/srep28757 |
Ejemplares similares
-
Noninvasive Evaluation of Metabolic Tumor Volume in Lewis Lung Carcinoma Tumor-Bearing C57BL/6 Mice with Micro-PET and the Radiotracers (18)F-Alfatide and (18)F-FDG: A Comparative Analysis
por: Wei, Yu-Chun, et al.
Publicado: (2015) -
A Pilot Study of (18)F-Alfatide PET/CT Imaging for Detecting Lymph Node Metastases in Patients with Non-Small Cell Lung Cancer
por: Zhou, Yue, et al.
Publicado: (2017) -
Tumor angiogenesis at baseline identified by (18)F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
por: Wei, Yuchun, et al.
Publicado: (2022) -
Pilot Prospective Evaluation of (18)F-Alfatide II for Detection of Skeletal Metastases
por: Mi, Baoming, et al.
Publicado: (2015) -
(18)F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer
por: Luan, Xiaohui, et al.
Publicado: (2016)